the aid library

LIST OPTIONS

Filter

2618

Investing in Mental Health: Evidence for Action

World Health Organization WHO (2013) C_WHO

In this report, potential reasons for this apparent contradiction between cherished human values and observed social actions are explored with a view to better formulating concrete steps that governments and other stakeholders can take to reshape social attitudes and public policy.

Download (345)

View PDF (431)

The clinical assessment of infants, preschoolers and their families

S. Mares; S. Woodgate IACAPAP (2017) C2

Introduction Chapter A.4 2017 edition

Download (166)

View PDF (142)

BuDb: A Curated Drug Discovery Database for Buruli Ulcer

Kwofie, S.K.; et al. (2022) CC

Journal of Computational Biophysics and ChemistryVol. 22, No. 01, pp. 31-41 (2023)

Download (817)

View PDF (439)

Rwanda: GUIDELINES ON VARIATIONS TO A REGISTERED PHARMACEUTICAL PRODUCT

Ministry of Health, Rwanda (2015) C2

Rwanda Guidelines for variation to registered pharmaceutical products.

Download (638)

View PDF (1048)

Guidelines on sanitation and health
recommended

World Health Organization WHO (2018) C_WHO

The new WHO Guidelines on Sanitation and Health summarize the evidence on the effectiveness of a range of sanitation interventions and provide a comprehensive framework for health-protecting sanitation, covering policy and governance measures, implementation of sanitation technologies, systems and b... more

External Link

Guidelines for Prevention and Control of Chikungunya Fever

World Health Organization, Regional Office South-East Asia (2009)

External Link

Culture and Mental Health: A review of culture related psychiatric conditions

S Karthick and Sangita Barwa (2017) CC

Psychol Behav Sci Int J 5(5): PBSIJ.MS.ID.555675 (2017)

Download (465)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (8271)

View PDF (816)

Panduan Penanganan Kanker Kandung Kemih Tipe Urotelial

Umbas, R., S. Hardjowijoto, C.A. Mochtar, et al., Indonesian Urological Association (2014) C1

Guidelines for Therapy and Management of Urothelial Urinary Bladder Cancer

Download (324)

View PDF (380)

Prevention of Depression and Promotion of Resilience. Consensus Paper

Pim Cuijpers, Laura Shields-Zeeman, Bethany Hipple Walters, Ionela Petrea European Union EU (2016) CC

EU Compass for Action on Mental Health and Well-being

Download (354)

View PDF (351)

ECOSOC Meeting “Addressing noncommunicable diseases and mental health: major challenges to sustainable development in the 21st century”

World Health Organization (2009) C_WHO

Discussion Paper "Mental health, poverty and development", July 2009

Download (147)

View PDF (418)

Strategic review of traps and targets for tsetse and African trypanosomiasis control

Kuzoe, F.A.; and S. Schofield UNDPWorld Bank (2005) C_WHO

Tsetse traps and targets (insecticide-impregnated screens) function by attracting the flies to a device that collects and/or kills them. Traps can be used for entomological surveillance, and also for control. Targets are simpler than traps, but are not used for surveillance. They are impregnated wit... more

Download (426)

View PDF (395)

State of the evidence 2021 - Modifications aiming to optimize acute malnutrition management in children under five

Action Against Hunger (2020) CC

This summary assesses the current state of evidence on each approach in tabular form, providing: the definition and objectives; evidence of effectiveness; operational considerations (e.g., training, staffing, and logistics); cost considerations and evidence on cost-effectiveness; operational success... more

Download (397)

View PDF (669)

Anxiety disorders in children and adolescents - Nature, development, treatment and prevention

R. M. Rapee IACAPAP (2018) C2

Anxiety disorders Chapter F.1 2018 edition

Download (259)

View PDF (267)

Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approa

World Health Organization WHO (2014) C_WHO

Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs... more

Download (302)

View PDF (408)

Towards a Core Set of Clinical Skills for Health-Related Community Based Rehabilitation in Low and Middle Income Countries

Jessica O'Dowd, Malcolm MacLachlan, Chapel Khasnabis, Priscille Geiser Disability, CBR & Inclusive Development Journal (DCIDJ) (2015) CC

This research aims to identify a core set of clinical skills for working in a Community Based Rehabilitation (CBR) setting, and to discuss whether they are appropriate for task shifting to a new or an alternative cadre of rehabilitation workers.

Download (708)

View PDF (486)

Intubation et extubation du patient de réanimation

Societé francaise d'anesthésie et de réanimation (SFAR) (2018) C2

Recommandations formalisées d'experts

External Link

World Report on Ageing and Health

John Beard, Alana Officer, Andrew Cassels et al. World Health Organization WHO (2015) C_WHO

Comprehensive public health action on population ageing is urgently needed. This will require fundamental shifts, not just in the things we do, but in how we think about ageing itself. The World report on ageing and health outlines a framework for action to foster Healthy Ageing built around the new... more

Download (290)

View PDF (303)

Public-private partnerships for health care infrastructure and services: considerations for policy makers in Ukraine

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

ndependent of the current conflict, the health sector in Ukraine faces several critical shortcomings. In particular, the country has an oversupply of hospitals and an undersupply of primary care and diagnostic facilities. Addressing these limitations will require substantial amounts of capital inves... more

External Link

Patient Decontamination in a Mass Chemical Exposure Incident: National Planning Guidance for Communities

US Department of Homeland Security, US Department of Health and Human Services (2014) C1

"Patient decontamination principles are set forth here from a strategic perspective, rather than a tactical one. The principles are meant to guide, but not specify, operational practices. The guidance is evidencebased to the extent possible and the supporting evidence is documented and briefly dis... more

Guidelines on sanitation and health recommended

Guidelines on sanitation and health
recommended